4D Molecular Therapeutics
Price & Volume
Stats
See more52W Range | $5.77-$36.25 |
Market Cap | $292.1M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $17,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$77.1M |
Diluted EPS | -$2.85 |
News
See moreYahoo Finance • 11 months ago
4D Molecular Therapeutics Inc CEO David Kirn Sells 102,303 Shares
Yahoo Finance • last year
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Cystic Fibrosis at 2023 NACFC
About
CEO | Dr. David H. Kirn M.D. |
Address | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 147 |
